Group One Trading
LRMR icon

Group One Trading’s Larimar Therapeutics LRMR Stock Holding History

Group One Trading’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-133,701
Closed -$520K – 8732
2025
Q3 		$432K Buy
133,701
+85,476
+177% +$321K ﹤0.01% 3845
2025
Q2 		$139K Buy
48,225
+47,100
+4,187% +$109K ﹤0.01% 4679
2025
Q1 		$2.42K Sell
1,125
-12,228
-92% -$38.6K ﹤0.01% 6942
2024
Q4 		$51.7K Buy
13,353
+9,273
+227% +$61.2K ﹤0.01% 5032
2024
Q3 		$26.7K Buy
+4,080
New +$32.8K ﹤0.01% 5070
2024
Q2 		– Sell
-8,638
Closed -$66.2K – 7159
2024
Q1 		$65.6K Buy
+8,638
New +$67.3K ﹤0.01% 4487
2023
Q3 		– Sell
-500
Closed -$1.89K – 8003
2023
Q2 		$1.56K Buy
+500
New +$2.04K ﹤0.01% 7160
2021
Q4 		– Sell
-1,000
Closed -$12K – 8570
2021
Q3 		$12K Buy
+1,000
New +$12K ﹤0.01% 7423
2021
Q2 		– Sell
-416
Closed -$4.7K – 8371
2021
Q1 		$6K Hold
416
– – ﹤0.01% 7202
2020
Q4 		$9K Hold
416
– – ﹤0.01% 5826
2020
Q3 		$6K Hold
416
– – ﹤0.01% 5580
2020
Q2 		$5K Buy
416
+391
+1,564% +$4.55K ﹤0.01% 5367
2020
Q1 		$0 Hold
25
– – ﹤0.01% 5528
2019
Q4 		$0 Buy
+25
New +$239 ﹤0.01% 5393
2019
Q3 		– Sell
-117
Closed -$2K – 5368
2019
Q2 		$2K Sell
117
-306
-72% -$8.15K ﹤0.01% 4760
2019
Q1 		$14K Buy
+423
New +$21.7K ﹤0.01% 4156
2018
Q3 		– Sell
-250
Closed -$31K – 5418
2018
Q2 		$31K Buy
250
+216
+635% +$18.3K ﹤0.01% 4198
2018
Q1 		$3K Sell
34
-285
-89% -$24.2K ﹤0.01% 4593
2017
Q4 		$18K Buy
+319
New +$14.4K ﹤0.01% 4184
2017
Q3 		– Sell
-402
Closed -$16.7K – 5004
2017
Q2 		$17K Buy
402
+181
+82% +$9.26K ﹤0.01% 4012
2017
Q1 		$12K Sell
221
-1,339
-86% -$66.5K ﹤0.01% 4066
2016
Q4 		$60K Sell
1,560
-250
-14% -$10.1K ﹤0.01% 3156
2016
Q3 		$72K Buy
1,810
+1,798
+14,983% +$81.7K ﹤0.01% 3127
2016
Q2 		$1K Sell
12
-251
-95% -$19.8K ﹤0.01% 4508
2016
Q1 		$21K Sell
263
-463
-64% -$36.6K ﹤0.01% 3718
2015
Q4 		$55K Buy
726
+20
+3% +$3.21K ﹤0.01% 3349
2015
Q3 		$271K Buy
+706
New +$318K ﹤0.01% 2271

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Group One Trading's LRMR Position: Q4 2025 in Review

Group One Trading sold out of Larimar Therapeutics (LRMR) in Q4 2025, closing a stake of 133,701 shares — an estimated $520K sold.

Group One Trading first reported a position in LRMR in Q3 2015 and held it in 27 quarters. The position peaked at $432K in Q3 2025. 136 funds tracked by Wall St. Rank hold LRMR as of Q4 2025.

  • Group One Trading reported no remaining Larimar Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 133,701 Larimar Therapeutics shares in Q4 2025, an estimated $520K.
  • Group One Trading first reported a position in Larimar Therapeutics in Q3 2015 and held it in 27 quarters.
  • Group One Trading's Larimar Therapeutics position peaked at $432K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.